Industry News
Australian biotech market watch 24/07/09
Ansell, CathRX, CSL, Primary Health Care, Sirtex, Living Cell Technologies, Biota, Cochlear [ + ]
New technique creates targeted knockout rats
Enables new animal models for understanding disease and conducting drug development. [ + ]
Mesoblast seeks TGA tick for stem cell products
Mesoblast to apply for regulatory approval of its bone fracture repair products. [ + ]
New drug may reduce heart attack damage
One-off drug delivery could dramatically improve treatment of Australia’s number one killer. [ + ]
Shake up in Australian stem cell research
The Australian Stem Cell Centre announces new funding scheme with four areas of emphasis. [ + ]
Australian biotech market watch 22/07/09
Cochlear, Fisher & Paykel, Ramsay, ResMed, Sigma, Sonic Health Care, Primary Health Care [ + ]
Life and death of a white blood cell
Cell division find prompts overhaul of immune response modelling. [ + ]
ChemGenex appoints new CCO
New chief commercial officer and senior vice president appointed ahead of omacetaxine launch in 2010. [ + ]
Formulaction and Scientific Solutions form alliance
The manufacturer of Turbiscan suspension stability instrumentation, Formulaction, is being represented in Australia by Scientific Solutions.
[ + ]Australian biotech market watch 17/07/09
Ansell, Cochlear, OMI, CSL, Ramsay, Sonic Health Care, Cellestis, Sirtex [ + ]
RNAi delivers knock-out punch
A new functional genomics facility has opened at Melbourne’s Peter MacCallum Cancer Centre, offering siRNA and shRNA approaches to gene silencing to Australian researchers. [ + ]
Find out what’s new in laboratory instrumentation
The Analytical Chemistry Group of the New South Wales branch of the RACI is holding a one-day seminar — What’s New in Laboratory Instrumentation — on 21 July 2009.
[ + ]New study offers hope for dyspeptic horses
BioProspect initiates study of Bioeffective A to treat common gastric problem in horses. [ + ]
'Copernicium' proposed as name for element 112
Element 112's existence has been officially confirmed by the International Union of Pure and Applied Chemistry and now the name 'copernicium' (Cp) has been proposed as its name.
[ + ]Glowing Phase II results for Clinuvel
Clinuvel announces positive results in Phase II Solar Urticaria study. [ + ]